Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021 - 2026

Report Code: HCR 0497 Report Format: PDF + Excel

Infection Surveillance Solutions Market Overview

Infection Surveillance Solutions Market size is estimated to reach $1.2 billion by 2026, growing at a CAGR of 13.7% during the forecast period 2021-2026. An infection Surveillance System is a system of surveillance planned to recognize probable communicable ailments prior to their spread to additional individuals in the facility. As per the Centers For Disease Control And Prevention (CDC), Infection Surveillance isto create, implement, support, and sustain evidence-based interventions to prevent healthcare-associated infections and organism transmissions”. An infection control practitioner (ICP) examines diseases that are existing inpatients and staff in hospitals. An infection control practitioner can be a registered nurse or microbiologist/technologist as approved by the American Society for Clinical Pathology (ASCP). An infection control practitioner may be involved in Infection Surveillance. Pneumonia is an infection of the air sacs in one or two of the lungs and may require infection surveillance. Electronic medical records (EMRs) are the lawful patient records that are developed in digital format in hospitals and ambulatory environments. Electronic medical records may be utilized as instruments for infection surveillance.

The dearth of sanitation, disobedience of recommended medication, and boost in the trend of self-medication has led to antibiotic resistance by bacteria resulting in a compelling need for a surveillance system to control the propagation of hospital-acquired infection and fatality connected with alarming ailments like pneumonia which is driving the growth of the Infection Surveillance Systems Market. The raised capacity of IT systems to carry out analytic processing in conjunction with technological progress in IT systems is set to propel the growth of the Infection Surveillance Solutions Market during the forecast period 2021-2026. This represents the Infection Surveillance Solutions Industry Outlook.

Report Coverage

The report: “Infection Surveillance Solutions Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Infection Surveillance Solutions Market.

By Infection Type: Surgical Site Infections (SSI), BloodStream Infections(BSI), UrinaryTract Infections (UIT), Others.
By Offering: Software (On-Premise, Cloud), Service (Maintenance and Support, Consultation and Training, Implementation Service).
By End User: Hospitals, Long-term Care Facilities, Others.
By Geography: North America (the U.S, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Rest of South America) and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America Infection Surveillance Solutions Market accounted for the highest revenue share in 2020 and it is poised to dominate the market over the period 2021-2026 owing to the boost in R&D activities in medical sciences, specifically in the U.S., where the United States Department Of Health And Human Services, which is a cabinet-level executive branch department of the U.S. federal government developed to safeguard the health of all Americans who may have electronic medical records and offering vital human services is generous in financing and keeping up the technological research in medical sciences in the North American region.
  • Infection Surveillance Solutions Market growth is being driven by the increase in hospital-associated infections in clinical settings like surgical site infections and the boost in acceptance of infection surveillance systems for ailments like pneumonia and to recognize probable healthcare-associated infections during a patient stay in hospitals. However, the soaring cost of software and the lack of suitable knowledge are some of the major factors hampering the growth of the Infection Surveillance Solutions Market. 
  • Infection Surveillance Solutions Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Infection Surveillance Solutions Market report. 

Infection Surveillance Solutions Market Share, By Offering, 2020(%)

Infection Surveillance Solutions Market

For more details on this report - Request for Sample

Infection Surveillance Solutions Market Segment Analysis – By Infection Type:

The Infection Surveillance Solutions Market based on Infection Type can be further segmented into Surgical Site Infections (SSI), Bloodstream Infections (BSI), urinary tract Infections (UIT), and Others. The Surgical Site Infections (SSI) Segment held the largest market share in 2020. This growth is owing to the increased vital complexities of surgery leading to great costs in both financial and human terms. The National Audit Commission (2000) has identified the conclusions of Hospital Acquired Infections (HAIs) on fatality and morbidity and the connected costs. The commission approximated that HAIs cost the National Health Service (NHS) over £1bn per year. Haley (1985) indicated that it is feasible to decrease infection rates by up to 38% by performing surveillance programs and feeding back outcomes to those included in inpatient care who may have electronic medical records. These determinants are fuelling the growth of the Surgical Site Infections (SSI) segment.

Furthermore, the urinary tract Infections (UIT) segment is estimated to grow with the fastest CAGR of 14.7% during the forecast period 2021-2026 owing to the increased cases of hospital-acquired urinary tract infections (HAUTI) with most cases connected to catheters (CAUTI) which may have associated electronic medical records.

Infection Surveillance Solutions Market Segment Analysis – By Offering:

The Infection Surveillance Solutions Market based on Offering can be further segmented into Software and Service. The Software segment held the largest market share in 2020. This growth is owing to the progressive technology as it provides effective management of patient data, investigation, and understanding. Elation Health is a cloud-based clinically aimed electronic health record solution for physicians seeking an ONC-ATCB approved EMR along with patient appointments, a patient portal, e-prescribing, and e-faxing. The increasing adoption of the Cloud sub-segment of the Software segment along with electronic medical records is fuelling the growth of this segment owing to the advantages offered by Cloud-like lesser maintenance cost, enhanced collaboration, good back-up and restore data features, and superior convenience.

Furthermore, the Service segment is estimated to grow with the fastest CAGR of 15.5% during the forecast period 2021-2026 owing to the greater acceptance of services in healthcare facilities equipped with the feature of electronic medical records.

Infection Surveillance Solutions Market Segment Analysis – By Geography:

The Infection Surveillance Solutions Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Infection Surveillance Solutions Market) held the largest share with 40% of the overall market in 2020. The growth of this region is owing to the increasing count of innovative product launches and the soaring concentration of key players like VigiLANZ Corporation in the region. The superior healthcare amenities like electronic medical records, the greater awareness of patients about more excellent healthcare services, and the trustworthy structure of reimbursement policies are estimated to propel the growth of the Infection Surveillance Solutions Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2021-2026. This growth is owing to factors like expanding endeavors to prevent hospital-acquired infections and to enhance complete healthcare with the utilization of electronic medical records. The rise of medical tourism is fuelling the progress of the Infection Surveillance Solutions Market in the Asia-Pacific region.

Infection Surveillance Solutions Market Drivers

Surveillance Of Infectious Ailments Like Pneumonia Is Projected To Drive The Growth Of Infection Surveillance Solutions Market:

As per World Health Organization (WHO), Pneumonia is responsible for 15% of all deaths of children under 5 years old, taking the lives of 808 694 children in 2017. Furthermore, WHO figures indicate that Pneumonia brought about by bacteria may be treated with antibiotics, but only one-third of children with pneumonia acquire the antibiotics they require. The increasing predominance of pneumonia among children is resulting in greater hospital admissions which are fuelling the demand for Infection Surveillance in the Infection Surveillance Solutions Market. In 2015, the Centers For Disease Control And Prevention (CDC) organized a point-prevalence survey in a sample of acute care hospitals in the U.S. and established that of the 427 healthcare-associated infections recognized, pneumonia was the most typical infection with 32% of those being ventilator connected. Patients accepting intrusive mechanical ventilation are at hazard for abundant complexities, inclusive of pneumonia. The high incidence of pneumonia is impelling the growth of the Infection Surveillance Solutions Market during the forecast period 2021-2026.

Technological Innovations Are Expected To Boost The Demand Of Infection Surveillance:

In addition to electronic medical records (EMRs), technological innovations are driving the growth of the Infection Surveillance Solutions market. Chromatic Health has developed the HAI Tracker software platform planned to boost effectiveness and streamline the surveillance procedure. The reciprocal and flexible interface leads users at all experience levels by way of nationally-identified criteria and it offers real-time feedback to permit healthcare personnel to confidently collect infection data. Users can act in accordance with the guided forms without memorizing infection criteria, guaranteeing constant reporting with a lesser staff workload. These kinds of technological innovations are driving the growth of the Infection Surveillance Solutions Market during the forecast period 2021-2026.

Infection Surveillance Solutions Market Challenges

Infection Surveillance Ineffectiveness Is Hampering The Growth Of Infection Surveillance Solutions Market:

A large count of hospitals still utilizes manual infection surveillance techniques where the Infection Preventionists (IPs) can invest hours analyzing through paper culture reports instead of electronic medical records to recognize possible Healthcare Acquired Infections (HAIs) or patient isolation interventions. The reports are frequently slowed, restricting opportunities for efficient HAI mediation. Abundant hospitals are turning to apply automated infection surveillance technology that can expedite patient data accumulation and investigation in real-time to boost surveillance effectiveness. The lack of automation in a considerable number of hospitals for infection surveillance is hampering the growth of the Infection Surveillance Solutions Market.

Infection Surveillance Solutions Marke Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Infection Surveillance Solutions Market. The key companies of this market include:

  1. RL Solutions
  2. GOJO Industries Inc.
  3. VigiLANZ Corporation
  4. Cerner Corporation
  5. IBM Corporation
  6. Atlas Medical Software
  7. Becton, Dickinson, and Company
  8. Premier Inc.
  9. Wolters Kluwer N.V
  10. Sunquest

Acquisitions/Product Launches:

  • In June 2021, VigiLanz, a clinical surveillance firm, declared the kick-off of a novel audit solution constructed on VigiLanz’s award-winning enterprise software platform. The novel solution, VigiLanz Audit, integrates VigiLanz’s existing security, quality, and risk products by ordering, automatizing, and making perfect audit processes.
  • In April 2021, VigiLanz, a clinical surveillance firm, declared the introduction of three novel event reporting solutions constructed on VigiLanz’s award-winning enterprise software platform. The novel solutions, VigiLanz Risk and Claims, VigiLanz Compliance, and VigiLanz Patient Relations, integrate VigiLanz’s current Dynamic Safety Surveillance product to augment the platform’s advantages and enhance hospitals’ bottom line by authorizing them to rapidly capture, monitor, and act on information, improving patient security and decreasing organizational hazard.

Related Reports:

Infection prevention & Control Market – Forecast (2021 - 2026)
Report Code: HCR 0022

Vehicle Surveillance Market – Forecast (2021 - 2026)
Report Code: ESR 0162

For more Lifesciences and Healthcare related reports, please click here

1. Infection Surveillance Solutions Market - Overview
    1.1 Definitions and Scope
2. Infection Surveillance Solutions Market - Executive Summary
    2.1 Market Revenue, Market Size, and Key Trends
    2.2 Key trends by Infection Type
    2.3 Key trends by Offering
    2.4 Key trends by Geography
3. Infection Surveillance Solutions Market - Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis– Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Infection Surveillance Solutions Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        3.1.1 Investment
        3.1.2 Revenue
        3.1.3 Venture Capital and Funding Scenario
5. Infection Surveillance Solutions Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Infection Surveillance Solutions Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Infection Surveillance Solutions Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Infection Surveillance Solutions Market – By Infection Type (Market Size –$Million/$Billion)
    8.1 Surgical Site Infections (SSI)
    8.2 Bloodstream Infections (BSI)
    8.3 Urinary Tract Infections (UTI)
    8.4 Others
9. Infection Surveillance Solutions Market – By Offering (Market Size –$Million/$Billion)
    9.1 Software
        9.1.1. On-Premise
        9.1.2. Cloud
    9.2 Service
        9.2.1. Maintenance and Support
        9.2.2. Consultation and Training
        9.2.3. Implementation Service
10. Infection Surveillance Solutions Market – By End User (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Long-term Care Facilities
    10.3 Others
11. Infection Surveillance Solutions Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Infection Surveillance Solutions Market - Entropy
13. Infection Surveillance Solutions Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Competition Matrix
        13.1.5 Best Practices for Companies
14. Infection Surveillance Solutions Market – Key Company List by Country Premium Premium
15. Infection Surveillance Solutions Market Company Analysis
    15.1Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best-efforts basis”.